Nya farmaka vid ateroskleros i sikte. Antioxidantia hämmar LDL-modifiering.

Translated title of the contribution: New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification

I. Björkhem, Lars Berglund

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification'. Together they form a unique fingerprint.